TreeWAS – Variant ID: rs68080462

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.177	0.823	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.173	0.827	0.000
C85.1 B-cell lymphoma, unspecified	0.165	0.835	0.000
C83.3 Large cell (diffuse)	0.157	0.843	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.153	0.847	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.146	0.854	0.000
C83.0 Small cell (diffuse)	0.142	0.858	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.130	0.870	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.126	0.874	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.124	0.876	0.000
C85.0 Lymphosarcoma	0.124	0.876	0.000
C88 Malignant immunoproliferative diseases	0.116	0.883	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.115	0.885	0.000
C86 Other specified types of T/NK-cell lymphoma	0.114	0.886	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.111	0.889	0.000
C83.6 Undifferentiated (diffuse)	0.110	0.890	0.000
C83.5 Lymphoblastic (diffuse)	0.110	0.890	0.000
C83.4 Immunoblastic (diffuse)	0.110	0.890	0.000
C83.2 Mixed small and large cell (diffuse)	0.110	0.890	0.000
C83.1 Small cleaved cell (diffuse)	0.109	0.891	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.105	0.895	0.000
C94 Other leukaemias of specified cell type	0.105	0.895	0.000
C93 Monocytic leukaemia	0.104	0.895	0.000
C84.5 Other and unspecified T-cell lymphomas	0.102	0.898	0.000
C84.4 Peripheral T-cell lymphoma	0.101	0.899	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.100	0.900	0.000
C95 Leukaemia of unspecified cell type	0.099	0.901	0.000
C83.7 Burkitt's tumour	0.096	0.903	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.093	0.907	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.093	0.907	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.093	0.907	0.000
C84.3 Lymphoepithelioid lymphoma	0.093	0.907	0.000
C84.2 T-zone lymphoma	0.093	0.907	0.000
C84.1 Sezary's diease	0.093	0.907	0.000
C84.0 Mycosis fungoides	0.093	0.907	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.091	0.908	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.084	0.916	0.000
C88.7 Other malignant immunoproliferative diseases	0.084	0.916	0.000
C88.3 Immunoproliferative small intestinal disease	0.084	0.916	0.000
C88.2 Gamma heavy chain disease	0.084	0.916	0.000
C88.1 Alpha heavy chain disease	0.084	0.916	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.082	0.918	0.000
C86.4 Blastic NK-cell lymphoma	0.082	0.918	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.082	0.918	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.082	0.918	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.082	0.918	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.082	0.918	0.000
C91 Lymphoid leukaemia	0.080	0.920	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.078	0.922	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.076	0.924	0.000
C94.7 Other specified leukaemias	0.075	0.925	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.075	0.925	0.000
C94.5 Acute myelofibrosis	0.075	0.925	0.000
C94.4 Acute panmyelosis	0.075	0.925	0.000
C94.3 Mast cell leukaemia	0.075	0.925	0.000
C94.2 Acute megakaryoblastic leukaemia	0.075	0.925	0.000
C94.1 Chronic erythraemia	0.075	0.925	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.075	0.925	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.075	0.925	0.000
C96.8 Histiocytic sarcoma	0.075	0.925	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.075	0.925	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.075	0.925	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.075	0.925	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.075	0.925	0.000
C96.3 True histiocytic lymphoma	0.075	0.925	0.000
C96.2 Malignant mast cell tumour	0.075	0.925	0.000
C96.1 Malignant histiocytosis	0.075	0.925	0.000
C96.0 Letterer-Siwe disease	0.075	0.925	0.000
C93.9 Monocytic leukaemia, unspecified	0.075	0.925	0.000
C93.7 Other monocytic leukaemia	0.075	0.925	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.075	0.925	0.000
C93.2 Subacute monocytic leukaemia	0.075	0.925	0.000
C93.0 Acute monocytic leukaemia	0.075	0.925	0.000
C93.1 Chronic monocytic leukaemia	0.075	0.925	0.000
C92 Myeloid leukaemia	0.072	0.927	0.000
C95.7 Other leukaemia of unspecified cell type	0.071	0.929	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.071	0.929	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.071	0.929	0.000
C95.0 Acute leukaemia of unspecified cell type	0.071	0.929	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.070	0.930	0.000
C81 Hodgkin's disease	0.066	0.934	0.000
C95.9 Leukaemia, unspecified	0.065	0.934	0.000
C91.0 Acute lymphoblastic leukaemia	0.061	0.939	0.000
C91.5 Adult T-cell leukaemia	0.058	0.942	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.058	0.942	0.000
C91.7 Other lymphoid leukaemia	0.058	0.942	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.058	0.942	0.000
C91.3 Prolymphocytic leukaemia	0.058	0.942	0.000
C91.2 Subacute lymphocytic leukaemia	0.058	0.942	0.000
C92.7 Other myeloid leukaemia	0.055	0.944	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.055	0.945	0.000
C82.4 Follicular lymphoma grade IIIb	0.054	0.946	0.000
C92.9 Myeloid leukaemia, unspecified	0.052	0.948	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.052	0.948	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.052	0.948	0.000
C92.5 Acute myelomonocytic leukaemia	0.052	0.948	0.000
C92.4 Acute promyelocytic leukaemia	0.052	0.948	0.000
C92.3 Myeloid sarcoma	0.052	0.948	0.000
C92.2 Subacute myeloid leukaemia	0.052	0.948	0.000
C91.4 Hairy-cell leukaemia	0.051	0.949	0.000
C82.6 Cutaneous follicle centre lymphoma	0.050	0.950	0.000
C82.5 Diffuse follicle centre lymphoma	0.050	0.950	0.000
C91.1 Chronic lymphocytic leukaemia	0.050	0.950	0.000
C81.2 Mixed cellularity	0.050	0.950	0.000
C81.0 Lymphocytic predominance	0.049	0.951	0.000
C92.1 Chronic myeloid leukaemia	0.048	0.951	0.000
C82.2 Large cell, follicular	0.048	0.952	0.000
C81.7 Other Hodgkin's disease	0.047	0.952	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.047	0.952	0.000
C81.3 Lymphocytic depletion	0.047	0.952	0.000
C91.9 Lymphoid leukaemia, unspecified	0.047	0.953	0.000
C82.0 Small cleaved cell, follicular	0.046	0.954	0.000
C82.3 Follicular lymphoma grade IIIa	0.045	0.955	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.042	0.957	0.001
C82.1 Mixed small cleaved and large cell, follicular	0.042	0.957	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.959	0.041
H65 Nonsuppurative otitis media	0.000	0.963	0.037
C81.1 Nodular sclerosis	0.035	0.965	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.032	0.968	0.000
H65.4 Other chronic nonsuppurative otitis media	0.000	0.968	0.032
C90.1 Plasma cell leukaemia	0.031	0.968	0.001
C90.3 Solitary plasmacytoma	0.030	0.969	0.001
H65.3 Chronic mucoid otitis media	0.000	0.969	0.031
H72 Perforation of tympanic membrane	0.000	0.970	0.030
H65-H75 Diseases of middle ear and mastoid	0.000	0.971	0.029
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.972	0.028
H72.0 Central perforation of tympanic membrane	0.000	0.973	0.027
H65.0 Acute serous otitis media	0.000	0.975	0.025
H65.2 Chronic serous otitis media	0.000	0.975	0.025
H72.2 Other marginal perforations of tympanic membrane	0.000	0.976	0.024
C81.9 Hodgkin's disease, unspecified	0.024	0.976	0.001
H72.1 Attic perforation of tympanic membrane	0.000	0.976	0.024
H73 Other disorders of tympanic membrane	0.000	0.976	0.024
H66 Suppurative and unspecified otitis media	0.000	0.977	0.023
H65.1 Other acute nonsuppurative otitis media	0.000	0.977	0.023
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.979	0.021
H68 Eustachian salpingitis and obstruction	0.000	0.979	0.021
H67 Otitis media in diseases classified elsewhere	0.000	0.979	0.021
H73.8 Other specified disorders of tympanic membrane	0.000	0.979	0.021
H69 Other disorders of Eustachian tube	0.000	0.979	0.021
H66.9 Otitis media, unspecified	0.000	0.980	0.020
C92.0 Acute myeloid leukaemia	0.019	0.981	0.000
Z48.8 Other specified surgical follow-up care	0.000	0.981	0.019
H66.3 Other chronic suppurative otitis media	0.000	0.982	0.018
H70 Mastoiditis and related conditions	0.000	0.982	0.018
C90.2 Plasmacytoma, extramedullary	0.016	0.983	0.002
H73.1 Chronic myringitis	0.000	0.983	0.017
H73.0 Acute myringitis	0.000	0.983	0.017
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.983	0.017
H66.4 Suppurative otitis media, unspecified	0.000	0.983	0.017
H69.8 Other specified disorders of Eustachian tube	0.000	0.983	0.016
M75.1 Rotator cuff syndrome	0.000	0.984	0.016
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.984	0.016
H66.0 Acute suppurative otitis media	0.000	0.984	0.016
H67.8 Otitis media in other diseases classified elsewhere	0.000	0.984	0.015
H67.1 Otitis media in viral diseases classified elsewhere	0.000	0.984	0.015
H67.0 Otitis media in bacterial diseases classified elsewhere	0.000	0.984	0.015
H68.1 Obstruction of Eustachian tube	0.000	0.984	0.015
H68.0 Eustachian salpingitis	0.000	0.984	0.015
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.984	0.015
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.000	0.984	0.015
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.985	0.015
H74 Other disorders of middle ear and mastoid	0.000	0.985	0.015
H69.0 Patulous Eustachian tube	0.000	0.985	0.015
H72.8 Other perforations of tympanic membrane	0.000	0.985	0.015
O80.0 Spontaneous vertex delivery	0.000	0.985	0.015
H71 Cholesteatoma of middle ear	0.000	0.985	0.015
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.987	0.013
H70.8 Other mastoiditis and related conditions	0.000	0.987	0.013
H70.2 Petrositis	0.000	0.987	0.013
H70.0 Acute mastoiditis	0.000	0.987	0.013
S82.40 Fracture of fibula alone (closed)	0.000	0.987	0.013
H69.9 Eustachian tube disorder, unspecified	0.000	0.988	0.012
H70.9 Mastoiditis, unspecified	0.000	0.988	0.012
H90.0 Conductive hearing loss, bilateral	0.000	0.989	0.011
H90 Conductive and sensorineural hearing loss	0.000	0.989	0.011
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.989	0.011
Z48 Other surgical follow-up care	0.000	0.989	0.011
H70.1 Chronic mastoiditis	0.000	0.989	0.011
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.989	0.011
Z48.9 Surgical follow-up care, unspecified	0.000	0.989	0.011
Chapter VIII Diseases of the ear and mastoid process	0.000	0.989	0.011
H74.1 Adhesive middle ear disease	0.000	0.989	0.010
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.990	0.010
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.990	0.010
H90-H95 Other disorders of ear	0.000	0.990	0.010
H90.2 Conductive hearing loss, unspecified	0.000	0.991	0.009
N92.3 Ovulation bleeding	0.000	0.991	0.009
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.000	0.991	0.009
H90.3 Sensorineural hearing loss, bilateral	0.000	0.992	0.008
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.000	0.992	0.008
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.000	0.992	0.008
H74.4 Polyp of middle ear	0.000	0.992	0.008
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.992	0.008
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.992	0.008
E83.3 Disorders of phosphorus metabolism	0.008	0.992	0.000
H90.5 Sensorineural hearing loss, unspecified	0.000	0.992	0.008
H74.0 Tympanosclerosis	0.000	0.993	0.007
H94 Other disorders of ear in diseases classified elsewhere	0.000	0.993	0.007
H91 Other hearing loss	0.000	0.993	0.007
J94.8 Other specified pleural conditions	0.007	0.993	0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.000	0.993	0.007
H60-H62 Diseases of external ear	0.000	0.993	0.007
H95.1 Other disorders following mastoidectomy	0.000	0.993	0.007
R40.0 Somnolence	0.000	0.993	0.007
H60.9 Otitis externa, unspecified	0.000	0.993	0.007
S00.8 Superficial injury of other parts of head	0.000	0.993	0.007
C90.0 Multiple myeloma	0.005	0.994	0.002
H91.8 Other specified hearing loss	0.000	0.994	0.006
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.000	0.994	0.006
H95.8 Other postprocedural disorders of ear and mastoid process	0.000	0.994	0.006
H60 Otitis externa	0.000	0.994	0.006
E83.4 Disorders of magnesium metabolism	0.006	0.994	0.000
Z48.0 Attention to surgical dressings and sutures	0.000	0.994	0.006
S82.4 Fracture of fibula alone	0.000	0.994	0.006
H94.8 Other specified disorders of ear in diseases classified elsewhere	0.000	0.994	0.005
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere	0.000	0.994	0.005
L05.9 Pilonidal cyst without abscess	0.000	0.994	0.006
H91.2 Sudden idiopathic hearing loss	0.000	0.994	0.005
H91.0 Ototoxic hearing loss	0.000	0.994	0.005
J94 Other pleural conditions	0.005	0.995	0.000
H91.3 Deaf mutism, not elsewhere classified	0.000	0.995	0.005
H60.8 Other otitis externa	0.000	0.995	0.005
H62 Disorders of external ear in diseases classified elsewhere	0.000	0.995	0.005
E83 Disorders of mineral metabolism	0.005	0.995	0.000
H91.1 Presbycusis	0.000	0.995	0.005
B18.2 Chronic viral hepatitis C	0.000	0.995	0.005
O80 Single spontaneous delivery	0.000	0.995	0.005
Z46.2 Fitting and adjustment of other devices related to nervous system and special senses	0.005	0.995	0.000
H60.4 Cholesteatoma of external ear	0.000	0.995	0.005
J94.2 Haemothorax	0.005	0.995	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.995	0.005
H47.3 Other disorders of optic disk	0.000	0.995	0.005
H47.1 Papilloedema, unspecified	0.000	0.995	0.005
J94.1 Fibrothorax	0.005	0.995	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.995	0.005
N72 Inflammatory disease of cervix uteri	0.000	0.995	0.005
H60.0 Abscess of external ear	0.000	0.995	0.004
H92 Otalgia and effusion of ear	0.000	0.995	0.005
H60.3 Other infective otitis externa	0.000	0.995	0.004
H91.9 Hearing loss, unspecified	0.000	0.996	0.004
R40 Somnolence, stupor and coma	0.000	0.996	0.004
B18 Chronic viral hepatitis	0.000	0.996	0.004
S82.41 Fracture of fibula alone (open)	0.000	0.996	0.004
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.004	0.996	0.000
H60.2 Malignant otitis externa	0.000	0.996	0.004
G56.0 Carpal tunnel syndrome	0.000	0.996	0.004
Y57.5 X-ray contrast media	0.004	0.996	0.000
B18.1 Chronic viral hepatitis B without delta-agent	0.000	0.996	0.004
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
J94.9 Pleural condition, unspecified	0.004	0.996	0.000
J94.0 Chylous effusion	0.004	0.996	0.000
H60.1 Cellulitis of external ear	0.000	0.996	0.004
L05.0 Pilonidal cyst with abscess	0.000	0.996	0.004
H62.8 Other disorders of external ear in diseases classified elsewhere	0.000	0.996	0.004
H62.4 Otitis externa in other diseases classified elsewhere	0.000	0.996	0.004
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere	0.000	0.996	0.004
H62.2 Otitis externa in mycoses	0.000	0.996	0.004
H62.1 Otitis externa in viral diseases classified elsewhere	0.000	0.996	0.004
H62.0 Otitis externa in bacterial diseases classified elsewhere	0.000	0.996	0.004
Y57.8 Other drugs and medicaments	0.004	0.996	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.004	0.996	0.000
E83.8 Other disorders of mineral metabolism	0.004	0.996	0.000
E83.2 Disorders of zinc metabolism	0.004	0.996	0.000
E83.0 Disorders of copper metabolism	0.004	0.996	0.000
R40.2 Coma, unspecified	0.000	0.996	0.004
L05 Pilonidal cyst	0.000	0.996	0.004
O80.1 Spontaneous breech delivery	0.000	0.996	0.004
E83.1 Disorders of iron metabolism	0.004	0.996	0.000
H93 Other disorders of ear, not elsewhere classified	0.000	0.996	0.004
R40.1 Stupor	0.000	0.996	0.004
N41.9 Inflammatory disease of prostate, unspecified	0.004	0.996	0.000
O80.8 Other single spontaneous delivery	0.000	0.996	0.004
W22.5 Trade and service area	0.004	0.996	0.000
H47.7 Disorder of visual pathways, unspecified	0.000	0.996	0.004
H47.6 Disorders of visual cortex	0.000	0.996	0.004
H47.5 Disorders of other visual pathways	0.000	0.996	0.004
H47.4 Disorders of optic chiasm	0.000	0.996	0.004
C67.2 Lateral wall of bladder	0.000	0.996	0.004
R03.1 Nonspecific low blood-pressure reading	0.004	0.996	0.000
H92.2 Otorrhagia	0.000	0.996	0.003
H47.2 Optic atrophy	0.000	0.996	0.003
B18.9 Chronic viral hepatitis, unspecified	0.000	0.997	0.003
B18.8 Other chronic viral hepatitis	0.000	0.997	0.003
B18.0 Chronic viral hepatitis B with delta-agent	0.000	0.997	0.003
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
H60.5 Acute otitis externa, non-infective	0.000	0.997	0.003
W22 Striking against or struck by other objects	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
N50.1 Vascular disorders of male genital organs	0.003	0.997	0.000
W20-W49 Exposure to inanimate mechanical forces	0.003	0.997	0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.997	0.003
T63.4 Venom of other arthropods	0.003	0.997	0.000
L90.0 Lichen sclerosus et atrophicus	0.000	0.997	0.003
W44 Foreign body entering into or through eye or natural orifice	0.003	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
W44.0 Home	0.003	0.997	0.000
H93.3 Disorders of acoustic nerve	0.000	0.997	0.003
H93.0 Degenerative and vascular disorders of ear	0.000	0.997	0.003
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
W26 Contact with knife, sword or dagger	0.003	0.997	0.000
B17.1 Acute hepatitis C	0.000	0.997	0.003
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
B15-B19 Viral hepatitis	0.000	0.997	0.003
I77.0 Arteriovenous fistula, acquired	0.003	0.997	0.000
W22.3 Sports and athletics area	0.003	0.997	0.000
W26.6 Industrial and construction area	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
H93.2 Other abnormal auditory perceptions	0.000	0.997	0.003
H80-H83 Diseases of inner ear	0.000	0.997	0.003
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
B17 Other acute viral hepatitis	0.000	0.997	0.003
W45 Foreign body or object entering through skin	0.003	0.997	0.000
H93.9 Disorder of ear, unspecified	0.000	0.997	0.003
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
H92.1 Otorrhoea	0.000	0.997	0.003
H93.8 Other specified disorders of ear	0.000	0.997	0.003
W24 Contact with lifting and transmission devices, not elsewhere classified	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
S62.61 Fracture of other finger (open)	0.000	0.997	0.003
Y58 Bacterial vaccines	0.003	0.997	0.000
U51 Admission status on psychiatric patients	0.003	0.997	0.000
W27 Contact with nonpowered hand tool	0.003	0.997	0.000
M23.8 Other internal derangements of knee	0.000	0.997	0.003
W22.2 School, other institution and public administrative area	0.003	0.997	0.000
B15 Acute hepatitis A	0.000	0.997	0.003
W23 Caught, crushed, jammed or pinched in or between objects	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.003	0.997	0.000
W45.8 Other specified place	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
W22.8 Other specified place	0.002	0.997	0.000
W22.6 Industrial and construction area	0.002	0.997	0.000
W22.4 Street and highway	0.002	0.997	0.000
W22.0 Home	0.002	0.997	0.000
W22.7 Farm	0.002	0.997	0.000
W22.1 Residential institution	0.002	0.997	0.000
O82.9 Delivery by Caesarean section, unspecified	0.000	0.997	0.003
O80-O84 Delivery	0.000	0.997	0.003
M25.54 Pain in joint (Hand)	0.000	0.997	0.003
W44.8 Other specified place	0.002	0.997	0.000
Z46.8 Fitting and adjustment of other specified devices	0.003	0.997	0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.000	0.997	0.003
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.000	0.997	0.003
W46 Contact with hypodermic needle	0.002	0.997	0.000
W43 Exposure to vibration	0.002	0.997	0.000
W42 Exposure to noise	0.002	0.997	0.000
W41 Exposure to high-pressure jet	0.002	0.997	0.000
W40 Explosion of other materials	0.002	0.997	0.000
W39 Discharge of firework	0.002	0.997	0.000
W38 Explosion and rupture of other specified pressurised devices	0.002	0.997	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.002	0.997	0.000
W36 Explosion and rupture of gas cylinder	0.002	0.997	0.000
W35 Explosion and rupture of boiler	0.002	0.997	0.000
W34 Discharge from other and unspecified firearms	0.002	0.997	0.000
W33 Rifle, shotgun and larger firearm discharge	0.002	0.997	0.000
W32 Handgun discharge	0.002	0.997	0.000
W31 Contact with other and unspecified machinery	0.002	0.997	0.000
W30 Contact with agricultural machinery	0.002	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
W13.9 Unspecified place	0.003	0.997	0.000
Y58.0 BCG vaccine	0.002	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
W44.9 Unspecified place	0.002	0.997	0.000
W44.5 Trade and service area	0.002	0.997	0.000
W44.7 Farm	0.002	0.997	0.000
W44.6 Industrial and construction area	0.002	0.997	0.000
W44.4 Street and highway	0.002	0.997	0.000
W44.3 Sports and athletics area	0.002	0.997	0.000
W44.2 School, other institution and public administrative area	0.002	0.997	0.000
W44.1 Residential institution	0.002	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.997	0.000
Y42.4 Oral contraceptives	0.002	0.997	0.000
Y42.2 Antithyroid drugs	0.002	0.997	0.000
B19 Unspecified viral hepatitis	0.000	0.997	0.002
W21 Striking against or struck by sports equipment	0.002	0.997	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.002	0.997	0.000
W24.6 Industrial and construction area	0.002	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
W20 Struck by thrown, projected or falling object	0.002	0.998	0.000
B15.9 Hepatitis A without hepatic coma	0.000	0.998	0.002
W23.3 Sports and athletics area	0.002	0.998	0.000
O82 Single delivery by Caesarean section	0.000	0.998	0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
M23.80 Other internal derangements of knee (Multiple sites)	0.000	0.998	0.002
W26.9 Unspecified place	0.002	0.998	0.000
W26.5 Trade and service area	0.002	0.998	0.000
W26.0 Home	0.002	0.998	0.000
W26.8 Other specified place	0.002	0.998	0.000
W26.7 Farm	0.002	0.998	0.000
W26.4 Street and highway	0.002	0.998	0.000
W26.3 Sports and athletics area	0.002	0.998	0.000
W26.2 School, other institution and public administrative area	0.002	0.998	0.000
W26.1 Residential institution	0.002	0.998	0.000
W28 Contact with powered lawn mower	0.002	0.998	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.998	0.002
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
K50.1 Crohn's disease of large intestine	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.998	0.002
O82.1 Delivery by emergency Caesarean section	0.000	0.998	0.002
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
B16 Acute hepatitis B	0.000	0.998	0.002
H82 Vertiginous syndromes in diseases classified elsewhere	0.000	0.998	0.002
K14.9 Disease of tongue, unspecified	0.002	0.998	0.000
W27.6 Industrial and construction area	0.002	0.998	0.000
W45.6 Industrial and construction area	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
B17.9 Acute viral hepatitis, unspecified	0.000	0.998	0.002
B17.2 Acute hepatitis E	0.000	0.998	0.002
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.000	0.998	0.002
W45.9 Unspecified place	0.002	0.998	0.000
W45.0 Home	0.002	0.998	0.000
W45.7 Farm	0.002	0.998	0.000
W45.5 Trade and service area	0.002	0.998	0.000
W45.4 Street and highway	0.002	0.998	0.000
W45.3 Sports and athletics area	0.002	0.998	0.000
W45.2 School, other institution and public administrative area	0.002	0.998	0.000
W45.1 Residential institution	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
W25 Contact with sharp glass	0.002	0.998	0.000
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.998	0.002
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
Z46 Fitting and adjustment of other devices	0.002	0.998	0.000
W24.8 Other specified place	0.002	0.998	0.000
W24.9 Unspecified place	0.002	0.998	0.000
W24.7 Farm	0.002	0.998	0.000
W24.5 Trade and service area	0.002	0.998	0.000
W24.4 Street and highway	0.002	0.998	0.000
W24.3 Sports and athletics area	0.002	0.998	0.000
W24.2 School, other institution and public administrative area	0.002	0.998	0.000
W24.1 Residential institution	0.002	0.998	0.000
W24.0 Home	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
R09.1 Pleurisy	0.002	0.998	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.000	0.998	0.002
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.998	0.002
B15.0 Hepatitis A with hepatic coma	0.000	0.998	0.002
W23.9 Unspecified place	0.002	0.998	0.000
W23.8 Other specified place	0.002	0.998	0.000
W23.6 Industrial and construction area	0.002	0.998	0.000
W23.5 Trade and service area	0.002	0.998	0.000
W23.0 Home	0.002	0.998	0.000
W23.7 Farm	0.002	0.998	0.000
W23.2 School, other institution and public administrative area	0.002	0.998	0.000
W23.1 Residential institution	0.002	0.998	0.000
W27.9 Unspecified place	0.002	0.998	0.000
W27.0 Home	0.002	0.998	0.000
W27.8 Other specified place	0.002	0.998	0.000
W27.7 Farm	0.002	0.998	0.000
W27.5 Trade and service area	0.002	0.998	0.000
W27.4 Street and highway	0.002	0.998	0.000
W27.3 Sports and athletics area	0.002	0.998	0.000
W27.2 School, other institution and public administrative area	0.002	0.998	0.000
W27.1 Residential institution	0.002	0.998	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.002	0.998	0.000
Q61.0 Congenital single renal cyst	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations